Following the publication of the Review by Etsuji Okamoto, ‘Is oseltamivir (Tamiflu®) safe? Re-examining the Tamiflu ‘ado’ from Japan’, published in the February 2010 issue of Expert Review of Pharmacoeconomics and Outcomes Research (Expert Rev. Pharmacoeconomics Outcomes Res. 10[1], 17–24 [2010]), it has been brought to our attention that an error was printed in . The original as printed can be seen on this page. The correct is shown on the next page.
The author and editors of Expert Review of Pharmacoeconomics and Outcomes Research would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.